Table 1 Clinical characteristics of low, normal, and high ABI groups
Total | Low ABI | Normal ABI | High ABI | χ2/t/z | P | |
|---|---|---|---|---|---|---|
N | 405 | 20 | 323 | 62 | ||
Male (n, %) | 278, 68.6% | 14, 70.0% | 220, 68.1% | 44, 71.0% | 0.215 | 0.898 |
Age (y) | 55.0 (47.0,64.5) | 59.5 (54.0,65.0) | 55.0 (47.0,63.0) | 60.0 (51.0,68.0) | 6.973 | 0.031 |
Diabetes duration (y) | 7.0 (2.0,13.5) | 13.5 (4.5,20.0) | 6.0 (2.0,12.0) | 10.0 (3.0,15.3) | 11.866 | 0.003 |
BMI | 24.80 (22.70,27.30) | 25.75 (23.08,27.08) | 24.70 (22.50,27.40) | 25.40 (23.40,27.33) | 1.253 | 0.534 |
Hypertension (n, %) | 214, 52.8% | 14, 70.0% | 161, 49.8% | 39, 62.9% | 6.045 | 0.049 |
Smoking (n, %) | 115, 28.4% | 9, 50.0% | 89, 29.8% | 17, 30.9% | 3.255 | 0.196 |
Diabetic retinopathy (n, %) | 79, 19.5% | 2, 10.0% | 58, 18.1% | 19, 31.1% | 6.744 | 0.034 |
Diabetic kidney disease (n, %) | 59, 14.6% | 3, 15.0% | 42, 13.0% | 14, 22.6% | 3.837 | 0.147 |
CRP (mg/L) | 0.80 (0.50,2.20) | 1.10 (0.50,5.53) | 0.80 (0.50,2.10) | 0.80 (0.50,3.05) | 1.619 | 0.445 |
UREA (mmol/L) | 5.70 (4.70,6.70) | 5.75 (5.18,7.60) | 5.60 (4.70,6.60) | 6.20 (5.00,8.00) | 9.351 | 0.009 |
Scr (μmol/L) | 58.00 (48.10,71.00) | 68.80 (51.50,112.50) | 57.00 (48.00,68.25) | 59.60 (48.90,76.50) | 8.596 | 0.014 |
UA (μmol/L) | 313.00 (255.00,394.00) | 329.00 (274.50,426.25) | 313.00 (256.50,329.00) | 305.50 (250.00,387.25) | 1.745 | 0.418 |
ACR | 11.80 (6.00,53.50) | 54.40 (5.45,188.38) | 10.30 (5.90,41.00) | 22.35 (7.00,264.10) | 10.618 | 0.005 |
TC (mmol/L) | 4.39 (3.68,5.09) | 4.69 (3.59,5.65) | 4.40 (3.67,5.13) | 4.27 (3.75,4.65) | 2.962 | 0.227 |
TG (mmol/L) | 1.49 (1.01,2.17) | 1.69 (1.06,2.11) | 1.49 (1.04,2.21) | 1.38 (0.89,2.08) | 1.506 | 0.471 |
HDL (mmol/L) | 1.06 (0.90,1.24) | 0.99 (0.84,1.13) | 1.06 (0.91,1.25) | 1.08 (0.94,1.27) | 3.194 | 0.203 |
LDL (mmol/L) | 2.71 ± 0.90 | 3.11 ± 1.00 | 2.73 ± 0.89 | 2.50 ± 0.82 | 3.623 | 0.028 |
HbA1C (%) | 8.70 (7.10,10.10) | 8.30 (6.88,9.98) | 8.70 (7.10,10.10) | 8.65 (7.10,10.00) | 0.288 | 0.866 |